The Gujarat government has outlined an ambitious roadmap to establish the state as a leading biomanufacturing and biotechnology hub by 2030, leveraging its strong pharmaceutical and chemical manufacturing ecosystem to accelerate growth in biotechnology, biopharmaceuticals, industrial biotechnology and advanced healthcare manufacturing.

The initiative forms part of Gujarat’s broader strategy to strengthen its position in the global bioeconomy and attract investments in high-value manufacturing sectors. State officials have emphasized that Gujarat’s well-established industrial infrastructure, skilled workforce and robust supply chains provide a strong foundation for expanding biotechnology and biomanufacturing capabilities.

Gujarat already plays a dominant role in India’s healthcare and manufacturing sectors, contributing approximately 40 percent of the country’s pharmaceutical production and housing one of India’s largest chemical manufacturing ecosystems. The state is also home to several major pharmaceutical companies, research institutions and industrial clusters, making it a strategic destination for biotechnology investments.

The proposed roadmap focuses on expanding capacity across key sectors, including biopharmaceuticals, vaccines, cell and gene therapies, biosimilars, industrial enzymes, synthetic biology, agricultural biotechnology and bio based manufacturing technologies. The government also plans to strengthen research infrastructure, promote innovation and encourage public private partnerships to accelerate commercialization of biotechnology products.

India’s biotechnology sector has witnessed rapid expansion in recent years. According to industry estimates, the country’s bioeconomy surpassed USD 150 billion in 2025 and is projected to exceed USD 300 billion by 2030, driven by growth in biopharmaceuticals, diagnostics, bio industrial products and healthcare innovation. Gujarat aims to capture a significant share of this expanding market through targeted investments and policy support.

The state government has identified biomanufacturing as a critical driver of economic growth, healthcare innovation and employment generation. Industry experts believe that advanced biomanufacturing technologies can strengthen supply chain resilience, reduce import dependence and improve India’s global competitiveness in pharmaceuticals and healthcare products.

Healthcare and biotechnology experts have welcomed Gujarat’s vision, noting that investments in biotechnology infrastructure, research capabilities and manufacturing ecosystems are essential for advancing precision medicine, vaccine development and next generation healthcare technologies. They also emphasized the importance of fostering collaboration between academia, industry and government to build a sustainable biotechnology ecosystem.

The roadmap aligns with India’s broader efforts to strengthen domestic manufacturing under initiatives such as Make in India, Atmanirbhar Bharat and the national bioeconomy strategy. Experts believe that Gujarat’s established pharmaceutical and chemical industries provide a competitive advantage in developing integrated biomanufacturing capabilities.

The state’s push to become a leading biomanufacturing hub by 2030 reflects the growing importance of biotechnology in healthcare, industrial innovation and economic development. As global demand for biotechnology products continues to rise, Gujarat aims to position itself as a key contributor to India’s emergence as a major global biotechnology and healthcare manufacturing destination.